Clinical Trial Update: Impact of Sotatercept on Pulmonary Artery and Right Ventricle Remodeling Imaging Assessed With 68Ga-FAPI PET/CT in Patients With PAH [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating sotatercept in pulmonary arterial hypertension, using 68Ga-FAPI PET/CT imaging to assess remodeling of the pulmonary arter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: University Hospital, Brest | Conditions: Pulmonary Arterial Hypertension (PAH) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING